The Global DBS Devices for Huntington Disease Market was projected to be USD 2.23 billion in 2023, and by 2030 it is anticipated to be worth USD 4.69 billion. The market is estimated to expand at a CAGR of 11.2% between 2024 and 2030.
Deep brain stimulation (DBS) is a novel treatment being investigated for the movement, cognitive, and behavioral disorders associated with Huntington's disease (HD). While there aren't any FDA-approved DBS devices for HD at the moment, the market for DBS devices as a whole is expanding quickly as more businesses create new DBS technologies and broaden their applications. Though the majority of DBS surgeries are performed for other neurological conditions like Parkinson's disease, the market for DBS devices specifically targeting HD is relatively small. However as more clinical trials show that DBS for HD is safe and effective, the market for DBS devices specifically designed for HD is anticipated to expand.
Key Market Insights:
Approximately 200,000 patients worldwide are thought to be eligible for DBS treatment for Huntington's disease. For patients with Huntington's disease, the average cost of DBS surgery and device implantation is between $80,000 and $100,000. Huntington's disease-related DBS devices normally have a battery life of three to five years, necessitating recurrent surgeries. Clinical research indicates that DBS can enhance motor function in patients with Huntington's disease by about 40–60% when compared to baseline levels.
Global DBS Devices for Huntington Disease Market Drivers:
Growing rates of HD will accelerate market expansion.
A rare inherited disorder, Huntington's disease (HD) affects about one in every 10,000 people worldwide. Even though HD is less common than other neurological disorders, more people are anticipated to get HD shortly. This is partially attributable to developments in genetic testing, which have facilitated the diagnosis of HD and the identification of people who are susceptible to the illness. The number of HD cases will increase, necessitating the development of novel and cutting-edge therapies like deep brain stimulation (DBS).
Growing acceptance of DBS as a therapeutic option will propel market expansion.
As more research demonstrates the safety and efficacy of deep brain stimulation (DBS), physicians and patients alike are beginning to recognize the potential benefits of DBS for Huntington's disease (HD). DBS is a comparatively non-invasive surgical procedure that has been demonstrated to enhance motor function and quality of life in individuals with HD. It can be tailored to target particular brain regions, potentially improving the accuracy and efficacy of the treatment. There will likely be a rise in demand for DBS devices for HD as more people become aware of DBS as a treatment option.
DBS Devices for Huntington Disease Market Challenges and Restraints:
No deep brain stimulation (DBS) device intended for the treatment of Huntington's disease (HD) has received approval from the US Food and Drug Administration (FDA). While some DBS devices are approved for use with other neurological conditions like Parkinson's disease, some are used off-label for HD. Because of worries about regulations and reimbursement, medical professionals might be reluctant to suggest off-label treatments. The FDA's denial of approval for DBS devices for HD may restrict the creation of new goods and market expansion. Deep brain stimulation (DBS) may not be widely known as a treatment option because many patients and healthcare professionals are not well informed about Huntington's disease. The use of DBS devices to treat Huntington's disease (HD) may also be discouraged by stigma and misconceptions surrounding the condition. Because of their worries about possible risks and the invasiveness of the procedure, healthcare providers may be hesitant to recommend DBS. DBS for Huntington's disease may not be adopted and grow as a result of this lack of awareness and stigma.
DBS Devices for Huntington Disease Market Opportunities:
The market for DBS devices for Huntington's disease (HD) offers numerous chances for expansion and innovation. Demand for efficient treatments like DBS is rising as people become more conscious of HD and its symptoms. To meet unmet medical needs and enhance patient outcomes, specialized DBS devices designed for HD may be developed. Furthermore, improvements in neurostimulation methods and technology could result in more focused and accurate DBS treatments for HD, improving efficacy and minimizing side effects. Additionally, partnerships between medical device manufacturers, academic institutions, and healthcare providers can hasten the creation and uptake of DBS devices for HD, creating fresh opportunities for market growth.
DBS DEVICES FOR HUNTINGTON DISEASE MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
11.2% |
|
Segments Covered |
By Type, End User, Application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Medtronic, Boston Scientific Corporation, Abbott Laboratories, Beijing PINS Medical Co., Ltd., SceneRay Corporation, Functional Neuromodulation Ltd., NeuroPace, Inc., AlevaNeurotherapeutics SA, Sapiens Steering Brain Stimulation B.V., Neuros Medical, Inc. |
Single-Channel DBS Devices
Multi-Channel DBS Devices
A sizable portion of the market is made up of single-channel DBS equipment. They use a single electrode positioned in a particular part of the brain. An implanted pulse generator (IPG) that delivers electrical signals to the brain is connected to this electrode. Multi-channel DBS devices, on the other hand, stimulate various brain regions using several electrodes. Targeting specific brain regions with greater flexibility and precision is possible with these devices, which can help treat complex HD symptoms.
Hospitals and Clinics
Home Care
Deep brain stimulation, or DBS, devices are primarily used in hospitals and clinics to treat Huntington's disease (HD). These facilities have dedicated departments that can handle both the surgical implant of the device and post-procedure care. Due to the specialized training and experience needed for the surgery, the use of DBS devices for HD is typically restricted to highly developed hospitals and clinics. With the assistance of caregivers or certified medical professionals, DBS devices for HD can occasionally be utilized in home care settings as well. For patients who have trouble traveling to hospitals or who require ongoing support at home, this option might be more practical.
Motor Symptoms
Psychiatric Symptoms
Cognitive Symptoms
Deep brain stimulation (DBS) devices are frequently used to treat motor symptoms, such as rigidity (stiffness), dystonia (muscle contractions), and chorea (involuntary movements), associated with Huntington's disease (HD). HD patients' quality of life can be significantly impacted by these symptoms, and DBS devices can help by enhancing motor control and minimizing involuntary movements. DBS can also be used to treat psychological symptoms like anxiety, irritability, and depression, though further study is required in this field. The use of DBS to treat cognitive symptoms like memory loss and difficulty thinking and making decisions is becoming more popular, but more research is needed to determine exactly how well it works to manage these aspects of HD.
North America
Europe
Asia-Pacific
Rest of the World
Because of the high prevalence of HD and the availability of state-of-the-art healthcare facilities, North America is anticipated to continue to be the largest market for DBS (deep brain stimulation) devices for HD patients. The United States is expected to continue to hold its dominant position in the North American market. The market for DBS devices for HD is expected to be the second largest in Europe, where HD prevalence is also expected to be significant. Important nations like Germany, France, and the United Kingdom are anticipated to propel market expansion. The industry is expected to grow at the fastest rate in Asia-Pacific because of rising awareness and adoption of DBS devices for HD. Japan, China, and India are important markets boosting this expansion. On the other hand, the lack of advanced healthcare infrastructure and low awareness of the advantages of DBS devices for HD in these regions are expected to cause the market in Africa, the Middle East, and Latin America to grow slowly.
COVID-19 Impact on the Global DBS Devices for Huntington Disease Market:
The COVID-19 pandemic has affected sales of deep brain stimulation (DBS) devices for Huntington's disease. Patients with Huntington's disease now receive irregular medical care, which delays diagnosis and treatment. The industry must keep creating DBS devices and giving them to patients who require them for medical treatment despite these obstacles.
Latest Trend/Development:
Due to DBS's success in treating other neurological disorders, there has been a noticeable upsurge in interest among researchers and medical professionals in investigating DBS as a potential therapy for Huntington's disease (HD) in the market for DBS devices. To evaluate the efficacy and safety of DBS specifically for HD, several clinical trials are being conducted to gather more evidence in favor of its use. Furthermore, advanced brain stimulation technologies specifically designed for HD and other neurological conditions are the focus of partnerships and collaborations between neurostimulation companies and pharmaceutical companies. Constant improvements in DBS device technology are improving safety, efficacy, and precision and may open up new treatment options for HD. Regulatory progress may be made as agencies review data from ongoing studies, even though there are currently no FDA-approved DBS devices for HD. This indicates a growing interest in and investment in DBS as a potential treatment option for Huntington's disease.
Key Players:
Medtronic
Boston Scientific Corporation
Abbott Laboratories
Beijing PINS Medical Co., Ltd.
SceneRay Corporation
Functional Neuromodulation Ltd.
NeuroPace, Inc.
AlevaNeurotherapeutics SA
Sapiens Steering Brain Stimulation B.V.
Neuros Medical, Inc.
Market News:
A partnership was formed in November 2023 between Otsuka Pharmaceutical and Nexstim NBS Therapy system to develop brain stimulation technology for neurological and psychiatric disorders.
To expand the options for DBS therapy, Neuropace initiated a clinical trial in September 2023 to evaluate the use of its RNS System for Parkinson's disease.
Positive findings from the ACHIEVE study demonstrated the efficacy of Percept PC+ in treating Tourette Syndrome in August 2023.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global DBS Devices for Huntington Disease Market was projected to be USD 2.23 billion in 2023, and by 2030 it is anticipated to be worth USD 4.69 billion. The market is estimated to expand at a CAGR of 11.2% between 2024 and 2030.
The Asia-Pacific region is likely to grow the most in the DBS devices for Huntington's disease market, due to the increasing prevalence of the disease in the region and the growing demand for advanced medical devices.
The high expense of DBS therapy, the scarcity of doctors who have undergone the necessary training, and the risk of adverse effects from using DBS devices are the main commercial obstacles for DBS devices for Huntington's disease.
The rising incidence of the condition, the rising need for minimally invasive surgical treatments, and the expanding knowledge of the advantages of DBS therapy are the main market drivers for DBS devices for Huntington's disease.
The hospitals segment is likely to grow the most in the DBS devices for Huntington's disease market, due to the increasing number of patients seeking treatment for the disease in hospital settings.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
